Literature DB >> 6941307

Reactivity of Langerhans cells with hybridoma antibody.

E Fithian, P Kung, G Goldstein, M Rubenfeld, C Fenoglio, R Edelson.   

Abstract

Reactivity of a monoclonal antibody with human Langerhans cells was demonstrated by a double-labeling immunofluorescence technique. Ia-bearing cells of the epidermis (Langerhans cells) were reactive with this antibody both in frozen sections and in cell suspensions prepared from human epidermis. This monoclonal antibody was unreactive with non-Ia-bearing epidermal cells and with peripheral blood B cells, T cells, and monocytes but did not bind to 70% of intrathymic lymphocytes. These observations further distinguish Langerhans cells from classical monocytes. Furthermore, this monoclonal antibody is a highly specific marker for the in vivo identification and in vitro isolation of Langerhans cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6941307      PMCID: PMC319384          DOI: 10.1073/pnas.78.4.2541

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders.

Authors:  M Lutzner; R Edelson; P Schein; I Green; C Kirkpatrick; A Ahmed
Journal:  Ann Intern Med       Date:  1975-10       Impact factor: 25.391

2.  SPECIFICITY OF ISOANTISERA AGAINST LEUKAEMIC AND THYMIC LYMPHOCYTES.

Authors:  A E REIF; J M ALLEN
Journal:  Nature       Date:  1963-12-28       Impact factor: 49.962

3.  Epidermal Langerhans cells bear Fc and C3 receptors.

Authors:  G Stingl; E C Wolff-Schreiner; W J Pichler; F Gschnait; W Knapp; K Wolff
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

4.  Immunofluorescent detection of human B cell alloantigens on S-Ig-positive lymphocytes and epidermal Langerhans cells.

Authors:  G Stingl; S I Katz; L D Abelson; D L Mann
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

5.  Ia antigen expression on human epidermal Langerhans cells.

Authors:  G Rowden; M G Lewis; A K Sullivan
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

6.  Epidermal Langerhans cells express Ia antigens.

Authors:  L Klareskog; U Tjernlund; U Forsum; P A Peterson
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

Review 7.  The langerhans cell.

Authors:  K Wolff
Journal:  Curr Probl Dermatol       Date:  1972

8.  Detection of Ia antigens on Langerhans cells in guinea pig skin.

Authors:  G Stingl; S I Katz; E M Shevach; E Wolff-Schreiner; I Green
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

Review 9.  The role of Langerhans cells in allergic contact hypersensitivity. A review of findings in man and guinea pigs.

Authors:  I Silberberg; R L Baer; S A Rosenthal
Journal:  J Invest Dermatol       Date:  1976-04       Impact factor: 8.551

10.  The Sézary syndrome: a malignant proliferation of helper T cells.

Authors:  S Broder; R L Edelson; M A Lutzner; D L Nelson; R P MacDermott; M E Durm; C K Goldman; B D Meade; T A Waldmann
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

View more
  97 in total

1.  Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling.

Authors:  S P Colgan; R M Hershberg; G T Furuta; R S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates.

Authors:  Ray Mc Dermott; Umit Ziylan; Danièle Spehner; Huguette Bausinger; Dan Lipsker; Mieke Mommaas; Jean-Pierre Cazenave; Graça Raposo; Bruno Goud; Henri de la Salle; Jean Salamero; Daniel Hanau
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

3.  Increased number of IgE positive Langerhans cells in the conjunctiva of patients with atopic dermatitis.

Authors:  A Yoshida; S Imayama; S Sugai; Y Kawano; T Ishibashi
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

Review 4.  Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells.

Authors:  M B Teunissen
Journal:  Histochem J       Date:  1992-10

5.  CD1a and langerin: acting as more than Langerhans cell markers.

Authors:  Norikatsu Mizumoto; Akira Takashima
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

6.  Feline atopic dermatitis. A model for Langerhans cell participation in disease pathogenesis.

Authors:  P J Roosje; D Whitaker-Menezes; M H Goldschmidt; P F Moore; T Willemse; G F Murphy
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

7.  Cutaneous host defense in leishmaniasis: interaction of isolated dermal macrophages and epidermal Langerhans cells with the insect-stage promastigote.

Authors:  R M Locksley; F P Heinzel; J E Fankhauser; C S Nelson; M D Sadick
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

8.  Dendritic cell populations in colon and mesenteric lymph nodes of patients with Crohn's disease.

Authors:  Marleen I Verstege; Fiebo J W ten Kate; Susanne M Reinartz; Cornelis M van Drunen; Frederik J M Slors; Willem A Bemelman; Florry A Vyth-Dreese; Anje A te Velde
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

9.  Diagnosis of pulmonary histiocytosis X by immunodetection of Langerhans cells in bronchoalveolar lavage fluid.

Authors:  S Chollet; P Soler; P Dournovo; M S Richard; V J Ferrans; F Basset
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

10.  Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.

Authors:  G Kaplan; E P Sampaio; G P Walsh; R A Burkhardt; T T Fajardo; L S Guido; A de Miranda Machado; R V Cellona; R M Abalos; E N Sarno
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.